PRPO logo.png
Precipio Signs Exclusive Manufacturing Agreement for IV-Cell™
June 04, 2019 09:10 ET | Precipio, Inc.
NEW HAVEN, Conn., June 04, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has entered into an exclusive subcontracting manufacturing...
PRPO logo.png
Precipio Conducts IV-Cell™ Validation Trial with a Prominent Laboratory
May 06, 2019 09:20 ET | Precipio, Inc.
NEW HAVEN, Conn., May 06, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it is in the process of completing a trial of its Proprietary IV-Cell...
Ny vetenskaplig arti
Ny vetenskaplig artikel från AroCell som konfirmerar värdet avTK 210 ELISA som verktyg inom läkemedelsutveckling och pre-klinisk forskning
December 11, 2018 02:30 ET | AroCell AB
AroCell AB (publ) meddelar idag att en vetenskaplig artikel med titeln ” Doxorubicin effects on leukemia and breast cancer cells in culture on the Thymidine Kinase 1 protein levels using AroCell...
A new scientific pub
A new scientific publication from AroCell confirming the value of AroCell TK 210 ELISA as a tool in drug discovery and development
December 11, 2018 02:30 ET | AroCell AB
A peer-reviewed article has been published in the journal Nucleosides, Nucleotides and Nucleic Acids, entitled “Doxorubicin effects on leukemia and breast cancer cells in culture on the Thymidine...
New Publication from
New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker
August 24, 2018 07:50 ET | AroCell AB
A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications...
energias.jpg
Global Mycoplasma Testing Market to Witness a CAGR of 12.3% during 2018-2024
July 27, 2018 10:13 ET | Energias Market Research
NEW YORK, July 27, 2018 (GLOBE NEWSWIRE) -- The global mycoplasma testing market was valued at USD 606.9 million in 2017, and is expected to reach USD 1358.2 million by 2024, at a CAGR of 12.3%...
Transparency Market Research
Global Cell Culture Market: Growing Demand for Artificial Organs to Pave Way for Market’s Growth -Transparency Market Research
July 18, 2016 05:30 ET | Transparency Market Research
Albany, NY, July 18, 2016 (GLOBE NEWSWIRE) -- The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare,...
Transparency Market Research
Global Cell Culture Market Expanding at CAGR of 7.1% from 2014 to 2022: Transparency Market Research
April 12, 2016 07:00 ET | Transparency Market Research
Albany, NY, April 12, 2016 (GLOBE NEWSWIRE) -- Transparency Market Research (TMR) has announced the publication of a new market study on the cell culture market. According to the research study,...